Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Recombinant Protein / Other Proteins

Recombinant Human ERCC1 Protein, N-His

Catalog #:   YHC29301 Specific References (50) DATASHEET
Applications: ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
Expression system: E. coli
Accession: P07992
Protein length: Met1-Pro297
Overview

Catalog No.

YHC29301

Expression system

E. coli

Species

Homo sapiens (Human)

Protein length

Met1-Pro297

Predicted molecular weight

34.87 kDa

Nature

Recombinant

Endotoxin level

Please contact with the lab for this information.

Purity

>90% as determined by SDS-PAGE.

Accession

P07992

Applications

ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress

Form

Lyophilized

Storage buffer

Lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol.

Reconstitution

Reconstitute in sterile water for a stock solution. A copy of datasheet will be provided with the products, please refer to it for details.

Shipping

In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.

Alternative Names

ERCC1, DNA excision repair protein ERCC-1

Data Image
  • SDS-PAGE
    SDS PAGE for recombinant Human ERCC1 protein
References

The interaction of XPG with TFIIH through p62 and XPD is required for the completion of nucleotide excision repair., PMID:40475541

High protein intake causes gene-length-dependent transcriptional decline, shortens lifespan and accelerates ageing in progeroid DNA repair-deficient mice., PMID:40416846

Targeting Cancer Stem Cells and Hedgehog Pathway: Enhancing Cisplatin Efficacy in Ovarian Cancer With Metformin., PMID:40387464

CARM1/PRMT4 facilitates XPF-ERCC1 heterodimer assembly and maintains nucleotide excision repair activity., PMID:40304182

Targeted inhibition of JMJD2C/MALAT1 axis compensates for the deficiency of metformin in reversing ovarian cancer platinum resistance., PMID:40280301

Excision repair cross complementation group 1 gene exon 3 skipping isoform presents selective cGAS-STING activation in platinum-sensitive lung adenocarcinoma., PMID:40258523

Germline variants in patients from the Iranian hereditary colorectal cancer registry., PMID:40223084

Comprehensive interrogation of synthetic lethality in the DNA damage response., PMID:40205037

Predictive Value of Excision Repair Cross Complementation Group 1 (ERCC1) by Immunohistochemistry for Determining Neoadjuvant Chemotherapy Response in Triple-Negative Breast Cancers., PMID:40008380

Beyond Nucleotide Excision Repair: The Importance of XPF in Base Excision Repair and Its Impact on Cancer, Inflammation, and Aging., PMID:39769376

Endothelial-Ercc1 DNA repair deficiency provokes blood-brain barrier dysfunction., PMID:39753531

Genetic signatures of ERCC1 and ERCC2 expression, along with SNPs variants, unveil favorable prognosis in SCLC patients undergoing platinum-based chemotherapy., PMID:39735668

The Ercc1-/Δ mouse model of XFE progeroid syndrome undergoes accelerated retinal degeneration., PMID:39604117

Lung cancer, platinum analog-based frontline treatment and pharmacogenetic limitations., PMID:39560009

m6A-Modified SNRPA Controls Alternative Splicing of ERCC1 Exon 8 to Induce Cisplatin Resistance in Lung Adenocarcinoma., PMID:39555714

The synergy between alkylating agents and ERCC1-XPF inhibitors is p53 dependent., PMID:39520092

Glioma-astrocyte connexin43 confers temozolomide resistance through activation of the E2F1/ERCC1 axis., PMID:39514365

Association of ERCC1 Gene Polymorphisms (rs3212986 and rs11615) With the Risk of Lung Cancer in a Population From Southeast Iran., PMID:39431656

Molecular architecture and functional dynamics of the pre-incision complex in nucleotide excision repair., PMID:39353945

miR-96-5p expression is sufficient to induce and maintain the senescent cell fate in the absence of stress., PMID:39325426

Calorie restriction increases the sensitivity of progeroid Ercc1Δ/- mice to acute (neuro)inflammation., PMID:39287878

ERCC1 which affects lipids metabolism and actin dynamics in coal workers' pneumoconiosis is a candidate biomarker for early warning and diagnosis., PMID:39283905

Improved health by combining dietary restriction and promoting muscle growth in DNA repair-deficient progeroid mice., PMID:39245994

Prognostic value of nucleotide excision repair and translesion DNA synthesis proteins in muscle-infiltrating bladder carcinoma., PMID:39237917

The Fanconi anemia pathway induces chromothripsis and ecDNA-driven cancer drug resistance., PMID:39181133

Potential association of SULT2A1 and ABCG2 variant alleles with increased risk for palbociclib toxicity., PMID:39092502

Does the XPA-FEN1 Interaction Concern to Nucleotide Excision Repair or Beyond?, PMID:39062528

A novel algorithm for the virtual screening of extensive small molecule libraries against ERCC1/XPF protein-protein interaction for the identification of resistance-bypassing potential anticancer molecules., PMID:39051064

The eEF2 kinase coordinates the DNA damage response to cisplatin by supporting p53 activation., PMID:39003251

Inhibition of topoisomerase 2 catalytic activity impacts the integrity of heterochromatin and repetitive DNA and leads to interlinks between clustered repeats., PMID:38977669

KHSRP has oncogenic functions and regulates the expression and alternative splicing of DNA repair genes in breast cancer MDA-MB-231 cells., PMID:38926398

Harmine inhibits pulmonary fibrosis through regulating DNA damage repair-related genes and activation of TP53-Gadd45α pathway., PMID:38924867

Multi-index comprehensive evaluation of the efficacy and response mechanism of immunotherapy in non-small cell lung cancer., PMID:38822977

USP14 increases the sensitivity of retinoblastoma to cisplatin by mediating the ferroptosis., PMID:38819674

Pharmacogenomic predictor of long-term residual chemotherapy-induced peripheral neuropathy in ovarian cancer survivors: A substudy of the GINECO Vivrovaire study., PMID:38776631

Prediction of response to promising first-line chemotherapy in ovarian cancer patients with residual peritoneal tumors: practical biomarkers and robust multiplex models., PMID:38767719

Dual‑regulated oncolytic adenovirus carrying ERCC1‑siRNA gene possesses potent antitumor effect on ovarian cancer cells., PMID:38757346

FTO blocks RNA translational activity via the loss of N6-methyladenosine methylation at 5' UTR regulated by RBM5 in cisplatin-resistant NSCLC., PMID:38742685

Formosanin C inhibits pulmonary metastasis by targeting stearyl CoA desaturase-1., PMID:38728921

Prognostic Significance of Excision Repair Cross-Complementation Group 1 on Circulating Tumor Cells for Nasopharyngeal Carcinoma., PMID:38716503

Metabolomic analysis of dietary-restriction-induced attenuation of sarcopenia in prematurely aging DNA repair-deficient mice., PMID:38689513

Gene expression markers in peripheral blood and outcome in patients with platinum-resistant ovarian cancer: A study of the European GANNET53 consortium., PMID:38676430

Persistent TFIIH binding to non-excised DNA damage causes cell and developmental failure., PMID:38664429

Exploring the impact of MiR-92a-3p on FOLFOX chemoresistance biomarker genes in colon cancer cell lines., PMID:38659583

DNA Repair Genetics and the Risk of Radiation Pneumonitis in Patients With Lung Cancer: A Systematic Review and Meta-analysis., PMID:38653664

p53 regulates diverse tissue-specific outcomes to endogenous DNA damage in mice., PMID:38514641

XPA tumor variant leads to defects in NER that sensitize cells to cisplatin., PMID:38500596

Hybrid Molecular and Functional Micro-CT Imaging Reveals Increased Myocardial Apoptosis Preceding Cardiac Failure in Progeroid Ercc1 Mice., PMID:38498063

Porcine alveolar macrophages host proteins interacting with African swine fever virus p72., PMID:38481793

Relationship between ERCC1 and XPC polymorphisms and the susceptibility to head and neck carcinoma: A systematic review, meta-analysis, and trial sequential analysis., PMID:38479279

Datasheet
$ 313
Product specifications
100 μg 313 1 mg 1629

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Recombinant Human ERCC1 Protein, N-His [YHC29301]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only